Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05157919 · ClinicalTrials.gov registry record · NA

Mobile App to Promote Family Caregiver Engagement in the Intensive Care Unit

A NA study of Family and Critical Care, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT05157919 is a NA study of Family and Critical Care that has completed, run by University of Nebraska. The registered enrollment target is 18 participants, below the 188-participant average among 9 other Family trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05157919, a NA study of Family and Critical Care, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized controlled pilot trial is to develop and test mobile app, Intensive Care Unit-Caregiver Activation Response, and Engagement (ICU-CARE). ICU-CARE provides a simulated learning environment to encourage family caregivers of mechanically ventilated patients to assess two patient symptoms, thirst and anxiety, and perform specific nonpharmacologic comfort measures to help alleviate patient symptom burden.

Interventions

  • BEHAVIORAL ICU-Care

Study Locations (1)

Nebraska

  • Nebraska Medicine - Omaha

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2020-01-06
Est. Completion 2022-06-01
Phase NA

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT05157919

The ClinicalTrials.gov registry entry for NCT05157919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 9 other Family trials with a reported enrollment target (90% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Family appearing as the primary indexed condition, and to 1 intervention - of which ICU-Care is the first listed.

NCT05157919 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT05157919 about?

NCT05157919 is a clinical study titled "Mobile App to Promote Family Caregiver Engagement in the Intensive Care Unit". The purpose of this randomized controlled pilot trial is to develop and test mobile app, Intensive Care Unit-Caregiver Activation Response, and Engagement (ICU-CARE). ICU-CARE provides a simulated learning environment to encourage family caregivers of mechanically ventilated patients to assess two p...

What is the current status of trial NCT05157919?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2020-01-06. Estimated completion is 2022-06-01.

What conditions does trial NCT05157919 study?

This clinical trial studies the following conditions: Family, Critical Care, Mobile Applications.

What interventions are being tested in trial NCT05157919?

The interventions under investigation include: ICU-Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT05157919?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05157919 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Family

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.